<DOC>
	<DOCNO>NCT01677936</DOCNO>
	<brief_summary>The objective study compare effect Raisins three time per day versus alternative snack three time per day blood sugar control cardiovascular risk factor ( weight , waist circumference , blood pressure , cholesterol level ) patient Type 2 Diabetes Mellitus . These effect study 12 week period .</brief_summary>
	<brief_title>Study Raisins Versus Alternative Snacks Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>Raisins often consider good food choice provide dietary fiber many health-promoting nutrient , antioxidant phytochemical . Like fruit , raisins devoid fat , saturate fat cholesterol , low sodium ; feature , combine high potassium content , high fiber , low glycemic index make potentially preferable food effect upon glycemic control cardiovascular risk factor .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Are generally healthy men woman old 18 year age Are willing able undergo inform consent process Have medical history Type 2 Diabetes Mellitus Have hemoglobin A1c 67.5 10 % Have body mass index ( BMI ) 25.0 39.9 kg/m2 Have blood pressure &gt; 100 mmHg systolic &gt; 70 mmHg diastolic Are willing able perform selfglucose monitor throughout study Are willing fast study visit Are willing able bring morning antidiabetes mellitus drug study visit Women must nonchildbearing potential define postmenopausal least 2 year surgically sterile ( i.e . bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) . If menopausal surgically sterile , woman childbearing potential must willing use : oral contraceptive another acceptable form birth control , double barrier birth control method condom occlusive cap ( e.g . diaphragm cervical/vault cap ) plus spermicidal agent ( e.g . foam , gel , film , cream , suppository ) . Are willing notify research staff change medical health &amp; concomitant medications/supplements course clinical trial Intolerance , dislike , unwillingness consume raisin comparator snack affiliate ingredient History great one drug allergy History great one `` food allergy '' Change antidiabetes mellitus medication within 3 month prior screen visit Change blood pressure and/or lipidaltering medication within 1 month screen visit Plans change current antidiabetes mellitus , blood pressure , lipidaltering medication course study Unwilling maintain current antidiabetes mellitus , blood pressure , lipidaltering medication dose course study History clinically significant diabetes mellitus complication , opinion investigator , may interfere successful completion trial History clinically significant diabetes mellitus kidney disease ( e.g . clinically significant proteinuria ) History severe high low blood sugar within past year , per Investigator discretion History severe high low blood sugar require hospitalization time past Subjects exclude within past 6 month , history myocardial infarction , acute coronary syndrome , stroke , cardiac / vascular surgical procedure ( e.g . atherosclerotic coronary heart disease bypass , carotid surgery , peripheral vascular bypass , stent placement , pacemaker placement , etc . ) , unstable angina , alteration treatment stable angina Subjects exclude time past , history clinically significant ventricular atrial dysrhythmias Subjects exclude time past , history New York Heart Association ( NYHA ) functional heart failure Class III great , define : CLASS III : Marked limitation physical activity , comfortable rest , less ordinary activity cause fatigue , palpitation dyspnea , CLASS IV : Unable carry physical activity without discomfort , symptom cardiac insufficiency rest , physical activity undertaken , discomfort increase Subjects exclude time past , history know increase QTc History seizure past year Is pregnant , breastfeed plan become pregnant course clinical trial Major surgical procedure within 30 day prior visit # 1 ( i.e . day sign informed consent document ) , current plan major surgical procedure study participation 30 day follow completion study related procedure History gastrointestinal malabsorption ( e.g . uncontrolled crohn 's disease , etc . ) history gastric bypass diversional bariatric surgery . Gastric band procedure also exclusionary adjust within 30 day prior visit # 1 ( i.e . day sign informed consent document ) , reasonable chance gastric band adjustment course study History ongoing malignancy . History malignancy acceptable eligibility successfully treat , evidence persistence recurrence malignancy within 5 year visit # 1 ( i.e . day sign informed consent document ) basal carcinoma skin `` situ '' cancer cervix successfully treat 30 day prior visit # 1 History organ transplant . History drug ( licit illicit ) alcohol abuse/addiction within 5 year visit # 1 ( i.e . day sign informed consent document ) Routinely consume 2 unit alcohol per day . A unit alcohol define 12 ounce ( 350 ml ) beer , 5 ounce ( 150 ml ) wine , 1.5 ounce ( 45 ml ) 80proof alcohol mixed drink . History clinically significant heart , vascular , hematologic , orthopedic , rheumatologic , muscle , brain , neurologic ( e.g . dementia , uncontrolled seizure disorder , etc . ) , gastrointestinal ( chronic hepatitis B C , malabsorptive intestinal disease uncontrolled crohn 's disease , ulcerative colitis , severe irritable bowel syndrome , significant gastrointestinal disease may interfere study participation and/or result ) , endocrine ( uncontrolled hyper hypothyroidism ) , ophthalmologic , infectious ( e.g . human immunodeficiency virus , tuberculosis , etc . ) immunologic , nephrologic , pulmonary ( e.g . poorly control asthma , poorly control chronic obstructive pulmonary disease , dyspnea , etc . ) , dermatologic , reproductive , psychiatric ( e.g . bipolar disorder , schizophrenia , borderline personality disorder , etc . ) disorder , condition would present unacceptable risk study subject , compromise acquisition interpretation study data , otherwise interfere study subject 's participation study . History severe uncontrolled depression base upon opinion Principal Investigator . Blood pressure &gt; 160 mmHg systolic &gt; 100 mmHg diastolic . Weight change ( increase decrease ) &gt; 5 pound 2 month ( history ) prior visit 1 Bradycardia define pulse less 50 beats/minute History clinically significant anemia Fasting serum lipoprotein value : LDLcholesterol , &gt; 160 mg/dl triglyceride , &gt; 500 mg/dl ( exclusionary screening ) Creatinine level screen &gt; 1.5 time upper range normal . Liver enzymes screen &gt; 2 time upper limit normal Potassium level upper range normal upon screen ( one repeat lab would permit initial elevated potassium level think possibly due laboratory error ) Known laboratory abnormality prior randomization Principal Investigator deem may pose unacceptable risk , compromise acquisition interpretation study data , otherwise interfere study subject 's participation study Known positive testing hepatitis B surface antigen , hepatitis C antibody , active hepatitis A immunoglobulin M , human immunodeficiency virus ( HIV ) Current past use insulin Use systemic corticosteroid ( intravenous , subcutaneous , intraarticular ) . Inhaled intranasal corticosteroid permit . Use antiobesity/weight maintenance drug therapy initial study visit , within 2 month initial study visit . Use digoxin cardiac antidysrhythmic drug Use anticoagulant ( warfarin , Coumadin ) Use dietary supplement acceptable , long supplement intake constant one month prior visit 1 , study participant plan continue supplement dose throughout study Known medical history clinical significance , condition would present unacceptable risk study subject , compromise acquisition interpretation study data , otherwise interfere study subject 's participation study per discretion Principal Investigator . Is employee immediate family member research staff . Donated blood within 2 month prior study entry , plan donate blood course study . Anticipation significant change job , job duty , job work hour , might impair ability willingness undergo studyrelated procedure timeline specify protocol , otherwise impede completion study . Anticipation reasonable likelihood move away research site , wherein move might impair ability willingness undergo studyrelated procedure within timeline specify protocol , otherwise impede completion study . Anticipation reasonable likelihood vacation time away home might impair ability willingness undergo studyrelated procedure within timeline specify study protocol , otherwise impede completion study . Planned anticipated major change lifestyle health practice , except allow study protocol . Treatment investigational product investigational device within 30 day prior visit # 1 ( i.e . day sign informed consent document ) plan potentially start investigational product use investigational device 30 day study subject completes study related procedure . Reasonable lifeexpectancy le 2 year . Any reason , opinion Investigator , individual study subject appropriate , suitable participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>diabetes</keyword>
	<keyword>blood pressure</keyword>
	<keyword>lipid</keyword>
	<keyword>waist circumference</keyword>
	<keyword>BMI</keyword>
</DOC>